
Episode #5
The Chemistry of Trust | Victoria Costa Paz
Victoria Costa Paz is the co-founder and CEO of Eywa, producing clinical-grade psilocybin through biosynthesis so that it can go where mushrooms cannot: into clinical trials, in front of regulators, and eventually onto a prescription pad. Her route there ran through Coca-Cola, a bank, and a startup in Mexico — each move made on the same question. What do I want to learn in order to become a better leader, and a better person? In this conversation with Mark Sephton she talks about what actually moves an investor at the early stages (it is not the technology), why she treats a fund's no as information rather than a judgement, and the discipline she credits above everything else: three goals, and keeping her word whether anyone is watching or not. There is also the matter of what happens when you make the people around you shine. One phone call, one flight, twenty new conversations for somebody else, and Victoria's argument for why that is not generosity so much as strategy. "They are not investing in your industry, they're not investing in your product, they are investing in you as a founder." ️ A new episode of The Female CEO podcast — female CEO insights and female founder interviews, every week.

